ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2416

Antibodies to Citrullinated Peptides in Patients with Juvenile Idiopathic Arthritis and Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype

Hannah Peckham1, Lauren Bourke1, Anna Radziszewska1, Maria J. Leandro2, Debajit Sen1, Geraldine Cambridge2 and Yiannis Ioannou1, 1Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 2Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-CCP antibodies, juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid factor (RF) positive polyarticular JIA (RF+ve pJIA) frequently progresses into adulthood with a clinical phenotype that ressembles rheumatoid arthritis (RA). Antibodies to cyclic citrullinated peptides (anti-CCP) have also been detected in a high proportion of sera from patients with RF+ve pJIA. We have previously described the use of an inherently autoreactive VH (variable heavy immunoglobulin chain) by anti-CCP in patients with early and also established adult RA [1]. Immunoglobulins derived from this gene (VH4-34) can be tracked using the rat monoclonal antibody, 9G4. This study profiles RF, anti-CCP and 9G4-CCP serology of a large adolescent JIA cohort compared with that of adult patients with RA.

Methods: Serum from 88 poly-JIA, enthesitis-related arthritis (ERA;n=29), extended oligoarthritis (EOA;n= 38), 31 gender/age matched controls, 35 adult RA and 30 age-matched healthy controls (HC). IgG, IgA and IgM isotypes of anti-CCP was tested. Cut-offs for positivity were defined by manufacturer’s instructions or determined with reference to known positive standards and expressed as arbitrary units (AU). RF status was determined by in-house ELISA. 9G4 expression on antibodies binding to CCP-coated ELISA plates was as previously described. A capture ELISA was used to measure serum total 9G4-IgM. Mann-Whitney U was used to compare groups and linear regression for relationships between variables.

Results: Of 88 patients with polyJIA, 65 were RF-ve with 4 (6%) positive for IgG-CCP. In RF+ve pJIA and RF+ve adult RA groups, 20/23 (87%) and 30/35 (86%) sera contained IgG-CCP respectively. 1 patient (with EOA) in adolescent patient group had IgG-CCP. Levels of IgG-CCP were similar between RF+ve pJIA and RF+ve RA but both IgA- and IgM-CCP levels were significantly lower in the adolescent group (p<0.01 for both). Binding of 9G4 to anti-CCP antibodies was significantly higher in the RF+ve pJIA vs RhF-ve pJIA (Median 9.8 vs 1.2; p<0.0001). Similar median levels of 9G4-CCP were present in RF+ve pJIA and adult RF+ve RA (p=0.13). 9G4 expression on serum total IgM was significantly higher in RF+ve pJIA patients compared with adult healthy control and JIA disease control groups (EOA, ERA and RF-ve pJIA all p<0.01), but similar to that of adult RF+ve RA.

Conclusion: This study is the first to describe the inherently autoreactive idiotope recognised by 9G4 being detected on anti-CCP antibodies in RF+ve pJIA. Restriction in VH gene usage in both JIA and RA patient immune systems may bias their immunoglobulin repertoire and be instrumental in the elicitation of anti-CCP antibodies. IgG-anti-CCP response of RF+ve pJIA and adult RA patients were similar. However, significantly higher levels of IgA- and IgM-anti-CCPs were present in adult RA patients. Interestingly, we previously showed that in adult RA with onset of <1 year, percentage of samples positive for IgM- and IgA-CCP followed, rather than preceded positivity for IgG-anti-CCP. This suggests that the emergence of IgG-antibodies to a citrullinated proteins may arise early in the underlying pathogenic process with a sequence of events not shared with conventional antibody responses to pathogens. 1.Cambridge G et al: PloS one 2014, 9(9):e107513.


Disclosure: H. Peckham, None; L. Bourke, None; A. Radziszewska, None; M. J. Leandro, None; D. Sen, None; G. Cambridge, None; Y. Ioannou, None.

To cite this abstract in AMA style:

Peckham H, Bourke L, Radziszewska A, Leandro MJ, Sen D, Cambridge G, Ioannou Y. Antibodies to Citrullinated Peptides in Patients with Juvenile Idiopathic Arthritis and Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/antibodies-to-citrullinated-peptides-in-patients-with-juvenile-idiopathic-arthritis-and-rheumatoid-arthritis-shared-expression-of-the-inherently-autoreactive-9g4-idiotype/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/antibodies-to-citrullinated-peptides-in-patients-with-juvenile-idiopathic-arthritis-and-rheumatoid-arthritis-shared-expression-of-the-inherently-autoreactive-9g4-idiotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology